{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:05:17Z","timestamp":1792591517049,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejpn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejpn.2026.05.001","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T15:09:51Z","timestamp":1777993791000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adjunctive cenobamate in children and adolescents \u2013 real-world data from a retrospective multicenter study"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6793-499X","authenticated-orcid":false,"given":"Leo","family":"Arkush","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinat","family":"Komargodski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagar Bernad","family":"Elazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimrit","family":"Uliel-Sibony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Chernuha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Hleihil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8606-853X","authenticated-orcid":false,"given":"Dror","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadassah","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3060-422X","authenticated-orcid":false,"given":"Tal","family":"Gilboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2222-5124","authenticated-orcid":false,"given":"Efrat","family":"Zohar-Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirit","family":"Lazinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-4440","authenticated-orcid":false,"given":"Elkana","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruria","family":"Ben Zeev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Heyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8675-2603","authenticated-orcid":false,"given":"Michal","family":"Tzadok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2026.05.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(24)00302-5","article-title":"Global, regional, and national burden of epilepsy, 1990\u20132021: a systematic analysis for the global burden of disease study 2021","author":"Feigin","year":"2025","journal-title":"Lancet Public Health"},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.001_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2026.05.001_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/epi4.70085","article-title":"Redefining drug-resistant epilepsy: insights from an Italian Delphi consensus study","author":"Vigevano","year":"2025","journal-title":"Epilepsia Open"},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.001_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s40263-021-00819-8","article-title":"Pharmacology of cenobamate: mechanism of action, pharmacokinetics, drug-drug interactions and tolerability","volume":"35","author":"Roberti","year":"2021","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.ejpn.2026.05.001_bib7","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1111\/epi.18297","article-title":"Real-world use of cenobamate in adults: efficacy and predictors of treatment response","volume":"66","author":"Loushy","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejpn.2026.05.001_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.seizure.2023.09.006","article-title":"Real-world experience with cenobamate: a systematic review and meta-analysis","volume":"112","author":"Makridis","year":"2023","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.001_bib9","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/epi.16525","article-title":"Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study","volume":"61","author":"Sperling","year":"2020","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ejpn.2026.05.001_bib10","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.1007\/s00415-024-12510-1","article-title":"Cenobamate: real-world data from a retrospective multicenter study","volume":"271","author":"Lauxmann","year":"2024","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.ejpn.2026.05.001_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s40263-024-01109-9","article-title":"Cenobamate as an early adjunctive treatment in drug-resistant focal-onset seizures: an observational cohort study","volume":"38","author":"Winter","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejpn.2026.05.001_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.950171","article-title":"Real-world experience treating pediatric epilepsy patients with cenobamate","volume":"13","author":"Makridis","year":"2022","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ejpn.2026.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108679","article-title":"Adjunctive use of cenobamate for pediatric refractory focal-onset epilepsy: a single-center retrospective study","volume":"130","author":"Varughese","year":"2022","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejpn.2026.05.001_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/epi.18586","article-title":"Real\u2010world use of cenobamate in pediatric focal epilepsies and developmental epileptic encephalopathies: a multicenter retrospective series","author":"Soto\u2010Insuga","year":"2025","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.001_bib15","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/epi.18257","article-title":"Cenobamate as add-on treatment for SCN8A developmental and epileptic encephalopathy","volume":"66","author":"Gjerulfsen","year":"2025","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.ejpn.2026.05.001_bib16","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1111\/epi.18426","article-title":"Lack of effectiveness and seizure worsening with cenobamate in pediatric patients with Dravet syndrome","volume":"66","author":"Cagigal","year":"2025","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.ejpn.2026.05.001_bib17","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1111\/epi.17427","article-title":"Successful treatment of adult Dravet syndrome patients with cenobamate","volume":"63","author":"Makridis","year":"2022","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.ejpn.2026.05.001_bib18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/epi.18308","article-title":"A multicenter cohort study on the efficacy, retention, and tolerability of cenobamate in patients with developmental and epileptic encephalopathies","volume":"66","author":"Buhleier","year":"2025","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.001_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s40120-025-00779-x","article-title":"Cenobamate for adjunctive treatment in adult and pediatric patients with refractory lennox-gastaut syndrome: a retrospective chart review","volume":"14","author":"Keough","year":"2025","journal-title":"Neurol Ther"},{"issue":"5","key":"10.1016\/j.ejpn.2026.05.001_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40120-024-00651-4","article-title":"Presurgical use of cenobamate for adult and pediatric patients referred for epilepsy surgery: expert panel recommendations","volume":"13","author":"Laxer","year":"2024","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ejpn.2026.05.001_bib21","series-title":"IBM SPSS Statistics for Windows, Version 29.0.2","year":"2023"},{"issue":"1","key":"10.1016\/j.ejpn.2026.05.001_bib22","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1528-1167.2012.03722.x","article-title":"Effect of dosage failed of first antiepileptic drug on subsequent outcome","volume":"54","author":"Brodie","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ejpn.2026.05.001_bib23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-Year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.ejpn.2026.05.001_bib24","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s40120-022-00400-5","article-title":"Dose adjustment of concomitant antiseizure medications during cenobamate treatment: expert opinion consensus recommendations","volume":"11","author":"Smith","year":"2022","journal-title":"Neurol Ther"},{"key":"10.1016\/j.ejpn.2026.05.001_bib25","article-title":"Adverse effects of cenobamate in pediatric epilepsy: Demographic considerations","volume":"29","author":"Iwamoto","year":"2025","journal-title":"J. Child Neurol."}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379826000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:35:21Z","timestamp":1784028921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379826000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":23,"alternative-id":["S1090379826000437"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.05.001","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjunctive cenobamate in children and adolescents \u2013 real-world data from a retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2026.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.","name":"copyright","label":"Copyright"}]}}